← Back to Search

EDSS with CO monitor for Schizophrenia

N/A
Waitlist Available
Led By Mary F Brunette, MD
Research Sponsored by Dartmouth-Hitchcock Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 months
Awards & highlights
No Placebo-Only Group

Summary

This randomized clinical trial among SMI smokers assessed whether the EDSS with carbon monoxide monitor and health-checklist feedback lead to higher rates of initiation of smoking cessation treatment, days of smoking abstinence and Fagerstrom Dependence scores, compared to use of the EDSS with checklist feedback alone.

Eligible Conditions
  • Schizophrenia
  • Smoking Addiction
  • Tobacco Use Disorder
  • Mental Illness

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Smoke

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: EDSS with CO monitorExperimental Treatment1 Intervention
Web-based electronic decision support system (EDSS) with carbon monoxide (CO) monitor and health-checklist
Group II: EDSS without CO monitorActive Control1 Intervention
Web-based electronic decision support system (EDSS) with health-checklist only
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
EDSS with CO feedback and health checklist
2011
N/A
~130

Find a Location

Who is running the clinical trial?

Dartmouth-Hitchcock Medical CenterLead Sponsor
538 Previous Clinical Trials
2,539,607 Total Patients Enrolled
32 Trials studying Schizophrenia
4,094 Patients Enrolled for Schizophrenia
U.S. Department of EducationFED
86 Previous Clinical Trials
54,608 Total Patients Enrolled
1 Trials studying Schizophrenia
303 Patients Enrolled for Schizophrenia
Bristol-Myers SquibbIndustry Sponsor
2,690 Previous Clinical Trials
4,097,416 Total Patients Enrolled
15 Trials studying Schizophrenia
785 Patients Enrolled for Schizophrenia
~9 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top